BTN3A Targeting Vγ9Vδ2 T Cells Antimicrobial Activity Against
Coxiella burnetii
Vγ9Vδ2 T cells
antimicrobial immunity
butyrophilin
therapeutic approaches
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
07
04
2022
accepted:
30
05
2022
entrez:
14
7
2022
pubmed:
15
7
2022
medline:
16
7
2022
Statut:
epublish
Résumé
Vγ9Vδ2 T cells have been reported to participate to the immune response against infectious diseases such as the Q fever caused by
Identifiants
pubmed: 35833118
doi: 10.3389/fimmu.2022.915244
pmc: PMC9272908
doi:
Substances chimiques
Antigens, CD
0
BTN3A1 protein, human
0
Butyrophilins
0
Receptors, Antigen, T-Cell, gamma-delta
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
915244Informations de copyright
Copyright © 2022 Gay, Mezouar, Cano, Foucher, Gabriac, Fullana, Madakamutil, Mège and Olive.
Déclaration de conflit d'intérêts
DO is cofounder and shareholder of Imcheck Therapeutics, Emergence Therapeutics, Alderaan Biotechnology and Stealth IO. CC, EF, MG, MF, and LM are employees and shareholders of Imcheck Therapeutics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.The authors declare that this study received funding from ImCheck Therapeutics. The funder had the following involvement in the study: study design, collection, analysis, interpretation of data and the writing of this article.
Références
Mol Med. 1999 May;5(5):301-12
pubmed: 10390546
Cell Mol Immunol. 2013 Jan;10(1):58-64
pubmed: 23147720
mBio. 2019 Apr 16;10(2):
pubmed: 30992359
Nucleic Acids Res. 2015 Jul 1;43(W1):W566-70
pubmed: 25969447
Microbes Infect. 2005 Mar;7(3):503-9
pubmed: 15823511
PLoS Pathog. 2006 Feb;2(2):e4
pubmed: 16518473
Infect Immun. 2007 Jul;75(7):3245-55
pubmed: 17438029
Blood. 2012 Sep 13;120(11):2269-79
pubmed: 22767497
Crit Rev Microbiol. 2020 Nov;46(6):689-702
pubmed: 33023358
Microbes Infect. 2003 May;5(6):491-8
pubmed: 12758278
Microbes Infect. 2005 Mar;7(3):518-28
pubmed: 15777667
Infect Immun. 1997 Oct;65(10):4267-72
pubmed: 9317036
J Immunol. 2017 Jun 1;198(11):4228-4234
pubmed: 28461569
Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1685-90
pubmed: 8256920
Front Cell Infect Microbiol. 2019 Jun 21;9:219
pubmed: 31293984
PLoS One. 2019 Dec 30;14(12):e0227005
pubmed: 31887178
FEBS Lett. 2003 Jun 5;544(1-3):4-10
pubmed: 12782281
Comp Immunol Microbiol Infect Dis. 2015 Aug;41:35-41
pubmed: 25982513
J Immunol. 2002 Dec 1;169(11):6309-15
pubmed: 12444137
Eur J Immunol. 1993 May;23(5):1177-80
pubmed: 8477812
Curr Opin Immunol. 2006 Oct;18(5):539-46
pubmed: 16870417
Cell Mol Life Sci. 2011 Jul;68(14):2409-17
pubmed: 21667064
Blood. 2011 Jul 7;118(1):129-38
pubmed: 21505189
Eur J Immunol. 2004 Aug;34(8):2089-99
pubmed: 15259006
Acc Chem Res. 2010 Sep 21;43(9):1216-26
pubmed: 20560544
Infect Immun. 1998 May;66(5):2107-14
pubmed: 9573096
Immunol Rev. 2020 Nov;298(1):74-83
pubmed: 33017054
PLoS One. 2013 Aug 02;8(8):e71245
pubmed: 23936496
Nat Rev Immunol. 2002 May;2(5):336-45
pubmed: 12033739
Immunol Rev. 2007 Feb;215:59-76
pubmed: 17291279
Immunity. 2014 Apr 17;40(4):490-500
pubmed: 24703779
Cell Rep. 2021 Jul 13;36(2):109359
pubmed: 34260935
PLoS Pathog. 2013 Jan;9(1):e1003119
pubmed: 23326234
Eur J Immunol. 2011 Jun;41(6):1619-28
pubmed: 21469127
Science. 2020 Feb 7;367(6478):
pubmed: 31919129
Clin Infect Dis. 1997 Feb;24(2):261-4
pubmed: 9114159
J Clin Invest. 1992 Jul;90(1):204-10
pubmed: 1386086
J Immunol. 2012 Aug 1;189(3):1285-93
pubmed: 22745375
Immunity. 2001 Jul;15(1):83-93
pubmed: 11485740
Front Immunol. 2018 Jul 11;9:1601
pubmed: 30050536
J Infect Dis. 2001 Oct 15;184(8):1082-5
pubmed: 11574927
Front Microbiol. 2019 Oct 29;10:2434
pubmed: 31749776
J Leukoc Biol. 2005 May;77(5):652-60
pubmed: 15668339
J Exp Med. 2017 Jun 5;214(6):1827-1841
pubmed: 28468758
J Immunol. 2007 Sep 1;179(5):3057-64
pubmed: 17709520
Sci Rep. 2021 Aug 11;11(1):16347
pubmed: 34381163
J Exp Med. 2003 Aug 4;198(3):391-7
pubmed: 12900516
Front Immunol. 2018 Dec 04;9:2812
pubmed: 30564234
Oncoimmunology. 2017 Sep 21;7(1):e1372080
pubmed: 29296524
Immunity. 2019 Apr 16;50(4):1043-1053.e5
pubmed: 30902636
Clin Diagn Lab Immunol. 2001 Sep;8(5):949-54
pubmed: 11527809
Emerg Infect Dis. 2013 Jul;19(7):1102-4
pubmed: 23763958
Nat Immunol. 2021 Mar;22(3):347-357
pubmed: 33432229
Immunol Lett. 2007 May 15;110(1):42-53
pubmed: 17451812
J Immunol. 2010 Aug 1;185(3):1770-6
pubmed: 20592281
J Immunol. 2002 Feb 1;168(3):1484-9
pubmed: 11801693